{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:03:10Z","timestamp":1782540190857,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04025-0","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T08:50:01Z","timestamp":1741942201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative analysis of demographics and clinical outcomes in patients with pemphigus vulgaris and foliaceus with high versus normal anti-desmoglein levels post-complete remission"],"prefix":"10.1007","volume":"317","author":[{"given":"Zeinab","family":"Aryanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Balighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arghavan","family":"Azizpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyousha","family":"RafieeTehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Khayyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"issue":"11","key":"4025_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8208","volume":"11","author":"Z Aryanian","year":"2023","unstructured":"Aryanian Z, Riyaz IZ, Balighi K, Ahmadzade A, Mahmoudi HR, Azizpour A, Hatami P (2023) Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: a report of five cases. Clin Case Rep 11(11):e8208. https:\/\/doi.org\/10.1002\/ccr3.8208","journal-title":"Clin Case Rep"},{"issue":"2024","key":"4025_CR2","doi-asserted-by":"publisher","first-page":"9572303","DOI":"10.1155\/2024\/9572303","volume":"24","author":"Z Aryanian","year":"2024","unstructured":"Aryanian Z, Balighi K, Esmaeli N, Daneshpazhooh M, Mazloomi Tootoonchi N, Razavi Z, Beigmohammadi F, Gul U, Khayyat A, Hatami P (2024) A comparative study of demographic and clinical criteria between male and female patients with pemphigus referred to a referral hospital in Iran. Dermatol Res Pract 24(2024):9572303. https:\/\/doi.org\/10.1155\/2024\/9572303","journal-title":"Dermatol Res Pract"},{"key":"4025_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15249","author":"K Balighi","year":"2021","unstructured":"Balighi K, Hatami P, Sheikh Aboli MJ, Daneshpazhooh M, Ghiasi M, Mahmoudi HR, Aryanian Z (2021) Multiple cycles of rituximab therapy for pemphigus: a group of patients with difficult- to-treat disease or a consequence of late rituximab initiation? Dermatol Ther. https:\/\/doi.org\/10.1111\/dth.15249. (Epub ahead of print)","journal-title":"Dermatol Ther"},{"issue":"5","key":"4025_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/vde.13094","volume":"33","author":"P Bizikova","year":"2022","unstructured":"Bizikova P, Linder KE, Mamo LB (2022) Trunk-dominant and classic facial pemphigus foliaceus in dogs\u2014comparison of anti-desmocollin-1 and anti-desmoglein-1 autoantibodies and clinical presentations. Vet Dermatol 33(5):414\u2013425. https:\/\/doi.org\/10.1111\/vde.13094. (Epub 2022 Jun 7)","journal-title":"Vet Dermatol"},{"issue":"2","key":"4025_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10238-022-00823-2","volume":"23","author":"X Lin","year":"2023","unstructured":"Lin X, Li X (2023) Assessment of anti-desmoglein antibodies levels and other laboratory indexes as objective comprehensive indicators of patients with pemphigus vulgaris of different severity: a single-center retrospective study. Clin Exp Med 23(2):511\u2013518. https:\/\/doi.org\/10.1007\/s10238-022-00823-2. (Epub 2022 Apr 21)","journal-title":"Clin Exp Med"},{"issue":"2","key":"4025_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/1346-8138.16568","volume":"50","author":"A Kawaguchi","year":"2023","unstructured":"Kawaguchi A, Matsuda M, Koga H, Ohata C, Hamada T, Mishima H, Yoshiura KI, Jinnin M, Minami H, Kanazawa N (2023) Anti-desmoglein 1 antibody-positive mother and antibody-negative child with Darier\u2019s disease. J Dermatol 50(2):250\u2013253. https:\/\/doi.org\/10.1111\/1346-8138.16568. (Epub 2022 Sep 8)","journal-title":"J Dermatol"},{"key":"4025_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2023.100208","volume":"7","author":"W Ramos","year":"2023","unstructured":"Ramos W, Rojas N, Ortega-Loayza AG, Tello M, Jim\u00e9nez G, Cuba-C\u00e1ceres N, Ronceros G, De La Cruz-Vargas JA, Vera-Ponce VJ, Guerrero N, Gutierrez EL (2023) Ultrastructural skin alterations of healthy subjects with anti-desmoglein 1 antibodies in endemic areas to pemphigus foliaceus: a case series. J Transl Autoimmun 7:100208. https:\/\/doi.org\/10.1016\/j.jtauto.2023.100208","journal-title":"J Transl Autoimmun"},{"issue":"4","key":"4025_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/ddg.14695","volume":"20","author":"J Pieper","year":"2022","unstructured":"Pieper J, Pollmann R, Eming R, Greene B, Hahmann M, Hertl M (2022) Disease progression and response to therapy in pemphigus based on a registry. J Dtsch Dermatol Ges 20(4):461\u2013467. https:\/\/doi.org\/10.1111\/ddg.14695","journal-title":"J Dtsch Dermatol Ges"},{"issue":"8","key":"4025_CR9","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/biomedicines10081774","volume":"10","author":"G Font","year":"2022","unstructured":"Font G, Walet-Balieu ML, Petit M, Burel C, Maho-Vaillant M, H\u00e9bert V, Chan P, Fr\u00e9ret M, Boyer O, Joly P, Calbo S, Bardor M, Golinski ML (2022) IgG N-glycosylation from patients with pemphigus treated with rituximab. Biomedicines 10(8):1774. https:\/\/doi.org\/10.3390\/biomedicines10081774","journal-title":"Biomedicines"},{"key":"4025_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107755","volume":"96","author":"Z Aryanian","year":"2021","unstructured":"Aryanian Z, Balighi K, Daneshpazhooh M, Karamshahi E, Hatami P, Goodarzi A, Tajalli M, Vance TM (2021) Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: a retrospective study. Int Immunopharmacol 96:107755. https:\/\/doi.org\/10.1016\/j.intimp.2021.107755. (Epub 2021 May 24)","journal-title":"Int Immunopharmacol"},{"issue":"46","key":"4025_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008801","volume":"96","author":"I Russo","year":"2017","unstructured":"Russo I, De Siena FP, Saponeri A, Alaibac M (2017) Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission. Medicine 96(46):e8801. https:\/\/doi.org\/10.1097\/MD.0000000000008801","journal-title":"Medicine"},{"issue":"1","key":"4025_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ced.12187","volume":"39","author":"M Daneshpazhooh","year":"2014","unstructured":"Daneshpazhooh M, Kamyab K, Kalantari MS, Balighi K, Naraghi ZS, Shamohammadi S, Mortazavizadeh SM, Ramezani A, Chams-Davatchi C (2014) Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris. Clin Exp Dermatol 39(1):41\u201347. https:\/\/doi.org\/10.1111\/ced.12187","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"4025_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000365079","volume":"229","author":"N Bellon","year":"2014","unstructured":"Bellon N, Andr\u00e9 C, Sbidian E, Ortonne N, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S (2014) The value of anti-desmoglein enzyme-linked immunosorbent assay in the immunological follow-up of pemphigus. Dermatology (Basel, Switzerland) 229(3):256\u2013262. https:\/\/doi.org\/10.1159\/000365079","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"3","key":"4025_CR14","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1111\/1346-8138.14603","volume":"46","author":"M Inaoki","year":"2019","unstructured":"Inaoki M, Oishi K, Nishijima C, Takehara K, Ishii K (2019) Two cases of pemphigus vulgaris in remission showing high titer of anti-desmoglein 3 antibodies. J Dermatol 46(3):e92\u2013e94. https:\/\/doi.org\/10.1111\/1346-8138.14603","journal-title":"J Dermatol"},{"issue":"3","key":"4025_CR15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jdermsci.2013.02.011","volume":"70","author":"K Kamiya","year":"2013","unstructured":"Kamiya K, Aoyama Y, Shirafuji Y et al (2013) A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetra- acetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris. J Dermatol Sci 70(3):190\u2013195","journal-title":"J Dermatol Sci"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04025-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04025-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04025-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T08:50:03Z","timestamp":1741942203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04025-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4025"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04025-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been conducted after obtaining the ethical approval of Tehran University of Medical Sciences ethics committee. Informed consent was obtained from all the participants and all methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication of data was obtained from all the participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"562"}}